Overview

Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This protocol is a prospective, open-label, multicenter, population pharmacokinetic and pharmacodynamic study of selected anti-infective agents in pregnant women being treated for suspected or documented infections.
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
Food and Drug Administration (FDA)
Treatments:
Anti-Bacterial Agents
Azithromycin
Ciprofloxacin
Gentamicins